Gene replacement therapy with onasemnogene abeparvovec in children with spinal muscular atrophy aged 24 months or younger and bodyweight up to 15 kg: an …

C Weiß, A Ziegler, LL Becker, J Johannsen… - The Lancet Child & …, 2022 - thelancet.com
Background Given the novelty of gene replacement therapy with onasemnogene abeparvovec
in spinal muscular atrophy, efficacy and safety data are limited, especially for children …

[HTML][HTML] Immunofluorescence staining of paraffin sections step by step

S Zaqout, LL Becker, AM Kaindl - Frontiers in neuroanatomy, 2020 - frontiersin.org
Immunofluorescence staining is the most frequently applied technique to detect and visualize
various molecules in biological samples. Many protocols can be found in the literature and …

[HTML][HTML] The clinical-phenotype continuum in DYNC1H1-related disorders—genomic profiling and proposal for a novel classification

LL Becker, HS Dafsari, J Schallner, D Abdin… - Journal of human …, 2020 - nature.com
Mutations in the cytoplasmic dynein 1 heavy chain gene (DYNC1H1) have been identified
in rare neuromuscular (NMD) and neurodevelopmental (NDD) disorders such as spinal …

Real‐world data on cannabidiol treatment of various epilepsy subtypes: A retrospective, multicenter study

F Kühne, LL Becker, T Bast, A Bertsche… - Epilepsia …, 2023 - Wiley Online Library
Objective Cannabidiol (CBD) is approved for treatment of Dravet syndrome (DS), Lennox‐Gastaut
syndrome (LGS), and tuberous sclerosis complex (TSC). Several studies suggest …

[HTML][HTML] Treatment of pediatric convulsive status epilepticus

LL Becker, A Gratopp, C Prager, CE Elger… - Frontiers in …, 2023 - frontiersin.org
Status epilepticus is one of the most common life-threatening neurological emergencies in
childhood with the highest incidence in the first 5 years of life and high mortality and morbidity …

[HTML][HTML] Corticosteroids in childhood epilepsies: A systematic review

LL Becker, AM Kaindl - Frontiers in Neurology, 2023 - frontiersin.org
Corticosteroids have been used for the treatment of patients with epilepsy for more than 6
decades, based on the hypothesis of inflammation in the genesis and/or promotion of epilepsy. …

Expanding the phenotype of NUP85 mutations beyond nephrotic syndrome to primary autosomal recessive microcephaly and Seckel syndrome spectrum disorders

…, Y Salzberg, B Fichtman, L Luise-Becker… - Human molecular …, 2021 - academic.oup.com
Primary autosomal recessive microcephaly and Seckel syndrome spectrum disorders (MCPH–SCKS)
include a heterogeneous group of autosomal recessive inherited diseases …

Monoallelic CRMP1 gene variants cause neurodevelopmental disorder

E Ravindran, N Arashiki, LL Becker, K Takizawa… - Elife, 2022 - elifesciences.org
Collapsin response mediator proteins (CRMPs) are key for brain development and function.
Here, we link CRMP1 to a neurodevelopmental disorder. We report heterozygous de novo …

Analysis of bihemispheric language function in pediatric neurosurgical patients using repetitive navigated transcranial magnetic stimulation

…, H Schneider, ML Neymeyer, LL Becker… - Journal of …, 2024 - thejns.org
OBJECTIVE Language dominance in the developing brain can vary widely across anatomical
and pathological conditions as well as age groups. Repetitive navigated transcranial …

Altered inhibition and excitation in neocortical circuits in congenital microcephaly

…, K Blaesius, YJ Wu, S Ott, N Kraemer, LL Becker… - Neurobiology of …, 2019 - Elsevier
Congenital microcephaly is highly associated with intellectual disability. Features of
autosomal recessive primary microcephaly subtype 3 (MCPH3) also include hyperactivity and …